Updated:
IMPACT BIOMEDICAL INC.
Impact Biomedical develops healthcare and wellness intellectual property through licensing, co-development and commercialization partnerships.
Overview
Impact Biomedical develops and licenses science and intellectual property for healthcare and wellness applications. Its business model uses licensing, co-development, joint ventures and other partnerships, with potential milestone and royalty payments tied to commercialization by partners. Research programs and prospective products remain distinct from regulatory approvals or completed commercialization. A September 16, 2026 disclosure described a proposed Zoar transaction rather than a completed acquisition. For fiscal 2025, ended 2025-12-31, its originally reported results included revenue of USD 32,000; a net loss of USD 11,838,000; cash used in operations of USD 1,890,000. At that year-end, it reported total assets of USD 17,405,000 and cash and cash equivalents of USD 3,000. Historical figures retain the originally filed amounts where later comparative figures differ.
Company overview
- Legal name
- IMPACT BIOMEDICAL INC.
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 0001834105
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $32,000 | -$11.8M | $17.4M | $3,000 | -$1.9M | |
| FY2024USD | — | -$24.7M | $20.3M | $2.0M | -$3.9M | |
| FY2023USD | — | -$4.4M | $44.6M | $1,000 | -$2.9M |
FY2024. Operating cash flow: shown as originally filed; later filings report different values for the same periods.
FY2023. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 10-Q | 10-Q | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research IMPACT BIOMEDICAL INC. in Altss
Track this company’s investors, transactions and relationships in Altss.